Baidu
map

偷拿21瓶医学中心研究样本回国!哈佛医学院中国访问学者被捕

2020-01-04 佚名 留美学子

2019年12月30日波士顿联邦助理法官大卫亨尼斯(David Hennessy)裁定:郑灶松哈佛访问学者兼癌症研究员,试图非法走私、盗窃哈佛大学某医学中心实验室内的研究样本到中国。因担心其有潜逃风险,法官还批准被告不予保释。据《纽约时报》报道,郑灶松12月9日准备乘坐海南航空公司482次航班,由波士顿直飞北京,被美国海关在其托运行李中搜出21瓶咖啡色液体,瓶子都用玻璃纸包好藏在袜子当中,他12月

2019年12月30日波士顿联邦助理法官大卫亨尼斯(David Hennessy)裁定:郑灶松哈佛访问学者兼癌症研究员,试图非法走私、盗窃哈佛大学某医学中心实验室内的研究样本到中国。因担心其有潜逃风险,法官还批准被告不予保释。

据《纽约时报》报道,郑灶松12月9日准备乘坐海南航空公司482次航班,由波士顿直飞北京,被美国海关在其托运行李中搜出21瓶咖啡色液体,瓶子都用玻璃纸包好藏在袜子当中,他12月10日被捕。

郑灶松先表示这些样本一点也不重要,和他的研究没有关系,之后,郑灶松承认自己未经实验室许可,偷出了部分样本,并从医学中心其他研究员那里复制了其他样品。

郑灶松在被捕的第二天被医学中心开除,其学术交流签证也被吊销。哈佛大学医学中心的发言人说,他们将配合调查。

检察官说,对郑灶松的调查还在继续,如果确认这些瓶子是从实验室盗走的,郑灶松将面临更多指控。可能会被指控偷运盗窃物资以及盗窃商业机密,两项罪名可能会为他带来高达10年的刑期。

郑灶松并不是第一个被发现或是被怀疑盗窃美国生物技术的中国留学生或是华裔。

美国国立卫生院NIH负责院外研究的副主任迈克尔劳尔(Michael Lauer)11月在美国国会听证时透露,截止2019年11月19日,国立卫生院有140多名学者因学术诚信或受外国影响被调查。

美国医学院校联合会首席科学家麦金尼说,美中两国科研人员有深厚的合作基础,不负责任的间谍活动将损害两国未来的合作前景。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1859866, encodeId=01f618598665b, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Jan 31 17:08:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023989, encodeId=e6d42023989cb, content=<a href='/topic/show?id=b3a0e341107' target=_blank style='color:#2F92EE;'>#研究样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73411, encryptionId=b3a0e341107, topicName=研究样本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Mon Dec 14 11:08:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669418, encodeId=54f316694180a, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Thu Apr 09 17:08:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516725, encodeId=85bf1516e2526, content=<a href='/topic/show?id=d3a3398e694' target=_blank style='color:#2F92EE;'>#哈佛医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39876, encryptionId=d3a3398e694, topicName=哈佛医学院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=809c11003616, createdName=ms6323715314570549, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557497, encodeId=d2fc155e49720, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1859866, encodeId=01f618598665b, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Jan 31 17:08:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023989, encodeId=e6d42023989cb, content=<a href='/topic/show?id=b3a0e341107' target=_blank style='color:#2F92EE;'>#研究样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73411, encryptionId=b3a0e341107, topicName=研究样本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Mon Dec 14 11:08:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669418, encodeId=54f316694180a, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Thu Apr 09 17:08:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516725, encodeId=85bf1516e2526, content=<a href='/topic/show?id=d3a3398e694' target=_blank style='color:#2F92EE;'>#哈佛医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39876, encryptionId=d3a3398e694, topicName=哈佛医学院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=809c11003616, createdName=ms6323715314570549, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557497, encodeId=d2fc155e49720, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1859866, encodeId=01f618598665b, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Jan 31 17:08:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023989, encodeId=e6d42023989cb, content=<a href='/topic/show?id=b3a0e341107' target=_blank style='color:#2F92EE;'>#研究样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73411, encryptionId=b3a0e341107, topicName=研究样本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Mon Dec 14 11:08:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669418, encodeId=54f316694180a, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Thu Apr 09 17:08:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516725, encodeId=85bf1516e2526, content=<a href='/topic/show?id=d3a3398e694' target=_blank style='color:#2F92EE;'>#哈佛医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39876, encryptionId=d3a3398e694, topicName=哈佛医学院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=809c11003616, createdName=ms6323715314570549, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557497, encodeId=d2fc155e49720, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
    2020-04-09 zhzhxiang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1859866, encodeId=01f618598665b, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Jan 31 17:08:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023989, encodeId=e6d42023989cb, content=<a href='/topic/show?id=b3a0e341107' target=_blank style='color:#2F92EE;'>#研究样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73411, encryptionId=b3a0e341107, topicName=研究样本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Mon Dec 14 11:08:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669418, encodeId=54f316694180a, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Thu Apr 09 17:08:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516725, encodeId=85bf1516e2526, content=<a href='/topic/show?id=d3a3398e694' target=_blank style='color:#2F92EE;'>#哈佛医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39876, encryptionId=d3a3398e694, topicName=哈佛医学院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=809c11003616, createdName=ms6323715314570549, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557497, encodeId=d2fc155e49720, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1859866, encodeId=01f618598665b, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Jan 31 17:08:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023989, encodeId=e6d42023989cb, content=<a href='/topic/show?id=b3a0e341107' target=_blank style='color:#2F92EE;'>#研究样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73411, encryptionId=b3a0e341107, topicName=研究样本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Mon Dec 14 11:08:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669418, encodeId=54f316694180a, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Thu Apr 09 17:08:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516725, encodeId=85bf1516e2526, content=<a href='/topic/show?id=d3a3398e694' target=_blank style='color:#2F92EE;'>#哈佛医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39876, encryptionId=d3a3398e694, topicName=哈佛医学院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=809c11003616, createdName=ms6323715314570549, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557497, encodeId=d2fc155e49720, content=<a href='/topic/show?id=7bec398e2e6' target=_blank style='color:#2F92EE;'>#哈佛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39872, encryptionId=7bec398e2e6, topicName=哈佛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7014916331, createdName=amyloid, createdTime=Mon Jan 06 04:08:00 CST 2020, time=2020-01-06, status=1, ipAttribution=)]
    2020-01-06 amyloid

相关资讯

一大批**医学中心要诞生了!

一大批国家医学中心和国家区域医疗中心要诞生了!近日,国家卫计委发布《“十三五”国家医学中心及国家区域医疗中心设置规划》,明确表示将按综合、肿瘤、心血管等专科类别设置国家医学中心;并在每个省(区、市)将设置建设1个综合类别的国家区域医疗中心。不仅如此,原则上还将在华北、东北、华东、中南、西南、西北6个区域分别设置专科类别的国家区域医疗中心。也就是说,一大批顶级三甲医院将有望迈入国家医学中心及国家

世界规模很大!一洲国际质子医学中心公开医院内景

世界规模最大的一洲国际质子医学中心公开医院内景。

中国医院格局将迎来大洗牌

中国医院格局将迎来重新洗牌?北京市卫计委领导在接受《新京报》采访时表示,未来医院会有一次重新洗牌的过程。那么中国医院格局正在、以及将会发生哪些巨大变化呢?

院感爆发!美国宾州盖辛格医学中心3名婴儿死亡

宾夕法尼亚州丹维尔市的盖辛格医学中心(Geisinger Medical Center)位于费城西北部约150英里的地方。从7月份开始,这里新生儿重症监护室的婴儿就开始陆续生病,先后8名婴儿患病,其中3名因细菌感染而死亡。就在上个月的新闻发布会上,这家医院的领导还坚称,他们对感染源一无所知。而上周五(11月8号),医院宣布他们发现了导致感染的罪魁祸首——铜绿假单胞菌(Pseudomonas aer

美国UC戴维斯医学中心正式签署A45肿瘤治疗技术

当生命科学的研究进入后基因组时代,肿瘤疾病的诊断和治疗也进入了一个崭新的阶段。研究人员正逐步从生物分子层面揭示肿瘤疾病的激发、促进、进展和转移。癌症治疗技术也从最初的以瘤体为单位治疗,进展到以细胞和基因为单位进行治疗的阶段。

上海建设亚洲医学中心城市“路线图”明晰

上海医疗”正逐步走向亚洲前列,品牌影响力在亚洲地区持续显现!昨天闭幕的首届亚洲医院创新与发展论坛传递信息:据专家对新加坡、东京、首尔等亚洲医学发达城市的比较研究显示,上海的发展潜力和势头向好。“上海建设亚洲医学中心城市已进入冲刺期!力争到2020年,上海的医疗服务能力和水平将基本实现与上海科技创新中心建设目标和亚洲医学中心城市定位相符合的目标。”上海市卫生健康委员会主任邬惊雷在论坛期间接受记者采

Baidu
map
Baidu
map
Baidu
map